Search results for "Drug Carrier"

showing 9 items of 329 documents

Clinical Trial Results of Peginterferons in Combination with Ribavirin

2003

Of the large number of patients chronically infected with hepatitis C virus (HCV), only about one third have progressive liver disease, and will eventually develop cirrhosis and hepatocellular carcinoma. These are the patients for whom effective antiviral treatment is most needed. Therapy is currently recommended for patients with chronic hepatitis C who have abnormal alanine aminotransferase (ALT) levels, detectable hepatitis C virus ribonucleic acid (HCV RNA) in the blood, and significant necroinflammatory changes and/or fibrosis on liver biopsy. The current gold standard in terms of treatment efficacy is the combination of peginterferon (PEG-IFN) and ribavirin. The overall sustained viro…

medicine.medical_specialtyCirrhosisHepatitis C virusInterferon alpha-2medicine.disease_causeAntiviral AgentsGastroenterologyDrug Administration SchedulePolyethylene Glycolsantiviral agentchemistry.chemical_compoundPharmacotherapyInternal medicineRibavirinmedicineHumansClinical Trials as TopicDrug CarriersHepatologymedicine.diagnostic_testbusiness.industryRibavirinInterferon-alphavirus diseasesHepatitis CHepatitis C Chronicmedicine.diseaseRecombinant Proteinsdigestive system diseasesTreatment OutcomechemistryLiver biopsyHepatocellular carcinomaImmunologyclinical trials hepatitis CDrug Therapy CombinationbusinessViral loadSeminars in Liver Disease
researchProduct

The dilemma for patients with chronic hepatitis C: treat now or warehouse?

2013

Dual therapy with peginterferon and ribavirin, the only treatent for chronic hepatitis C available In Italy and in many other ountries worldwide up to 2013, obtains satisfactory response ates in infections with hepatitis C virus (HCV) genotype 2, but far rom optimal for other genotypes [1,2]. Eradication requires 6–12 onths of therapy, with significant inconvenience for patients: dverse reactions force premature termination in about 20% of atients and reduced the quality of life for almost all who persist n treatment. In view of the important and prolonged side effects, nterferon-based treatment is perceived as a nightmare by many symptomatic,well-being, socially activepatients (the largema…

medicine.medical_specialtyPediatricsTime FactorsProlineHepatitis C virusAlpha interferonmedicine.disease_causeAntiviral AgentsTelaprevirPolyethylene Glycolschemistry.chemical_compoundLiver diseaseBoceprevirDrug DiscoveryRibavirinmedicineHumansProtease InhibitorsAdverse effectWatchful WaitingDrug CarriersHepatologybusiness.industryRibavirinGastroenterologyInterferon-alphaHepatitis C Chronicmedicine.diseaseSurgeryEastern europeanchemistryHCVDrug Therapy CombinationbusinessOligopeptidesmedicine.drugDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo

2012

Abstract Introduction Bisphosphonates are important and effective drugs in oncology and osteoporosis therapy. They accumulate in the bone matrix becoming released and active by bone resorption. This leads to effective inhibition of tumor cells and bone degradation. A side effect of bisphosphonates similar to other drugs like denosumab is osteonecrosis of the jaws (ONJ). This problem mostly occurs after tooth extraction. We studied the cytoprotectant dexrazoxane known from anthracycline chemotherapy for cytoprotection in nitrogen-containing bisphosphonate treated cells and in the rabbit tibia model to evaluate a possible value in ONJ management. Materials & methods Human osteoblasts (HOB) P2…

medicine.medical_treatmentOsteoporosisCell Culture TechniquesGingivaTetrazolium SaltsApoptosisPharmacologyCell morphologyZoledronic AcidOsteogenesisColoring AgentsDrug CarriersBone Density Conservation AgentsDiphosphonatesImidazolesFluoresceinsResorptionDenosumabModels AnimalFemaleCollagenRabbitsOral SurgeryRazoxanemedicine.drugmedicine.medical_specialtyCell SurvivalProtective AgentsBone resorptionCell LinemedicineAnimalsHumansBone ResorptionCell ShapeFluorescent DyesOsteoblastsTibiabusiness.industryFibroblastsBisphosphonatemedicine.diseaseSurgeryThiazolesDurapatiteZoledronic acidOtorhinolaryngologyCytoprotectionSurgeryDexrazoxanebusinessJournal of Cranio-Maxillofacial Surgery
researchProduct

Biocompatible Lipid Nanoparticles as Carriers to Improve Curcumin Efficacy in Ovarian Cancer Treatment

2017

Curcumin is a natural molecule with proved anticancer efficacy on several human cancer cell lines. However, its clinical application has been limited due to its poor bioavailability. Nanocarrier-based drug delivery approaches could make curcumin dispersible in aqueous media, thus overtaking the limits of its low solubility. The aim of this study was to increase the bioavailability and the antitumoral activity of curcumin, by entrapping it into nanostructured lipid carriers (NLCs). For this purpose here we describe the preparation and characterization of three kinds of curcumin-loaded NLCs. The nanosystems allowed the achievement of a controlled release of curcumin, the amounts of curcumin r…

nanostructured lipid carriers curcumin drug release cancer epithelial ovarian cellsCurcuminNanoparticleAdministration Oral02 engineering and technologyPharmacologynanostructured lipid carrier03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsNanoparticleSettore BIO/10 - BiochimicamedicineHumanscancerParticle SizeDrug Carrierdrug releaseCell ProliferationOvarian NeoplasmsDrug CarriersOvarian NeoplasmChemistry (all)General ChemistryLipid021001 nanoscience & nanotechnologyBiocompatible materialmedicine.diseaseControlled releaseLipidsBioavailabilitychemistryAgricultural and Biological Sciences (all)Settore CHIM/09 - Farmaceutico Tecnologico Applicativo030220 oncology & carcinogenesisDrug deliveryCurcuminNanoparticlesFemaleNanocarriers0210 nano-technologyGeneral Agricultural and Biological SciencesOvarian cancerDrug Delivery Systemepithelial ovarian cellHuman
researchProduct

Interazioni tra nanotubi e molecole organiche

Nell'ampio scenario dei nanomateriali, i sistemi nanotubolari godono di un consolidato e crescente interesse sia nell'ambito scientifico che industriale. Fra la miriade di sistemi tubolari, i più utilizzati sono i nanotubi a base di carbonio e carbon nanohorns e più recentemente, vista l'elevata biocompatibilità e il loro basso costo, nanotubi inorganici quali i nanotubi di allosite. la funzionalizzazione di questi materiali con diverse tipologie di molecole organiche, ha permesso la sintesi di materiali che potrebbero o hanno trovato applicazione come filler polimerici, come supporti eterogenei in catalisi e nel campo del drug carrier e delivery. Inoltre, nel caso di nanotubi di allosite, …

nanotubi allosite funzionalizzazione catalisi filler polimerici drug carrier e deliverySettore CHIM/06 - Chimica Organica
researchProduct

NOVEL PAHY-GRAFT COPOLYMERS AS MICELLAR DRUG CARRIER FOR ANTICANCER DRUGS

2009

polymer-drug carrier-micelles
researchProduct

Development of New Targeted Inulin Complex Nanoaggregates for siRNA Delivery in Antitumor Therapy.

2021

Here, a novel strategy of formulating efficient polymeric carriers based on the already described INU-IMI-DETA for gene material whose structural, functional, and biological properties can be modulated and improved was successfully investigated. In particular, two novel derivatives of INU-IMI-DETA graft copolymer were synthesized by chemical functionalisation with epidermal growth factor (EGF) or polyethylenglycol (PEG), named INU-IMI-DETA-EGF and INU-IMI-DETA-PEG, respectively, in order to improve the performance of already described “inulin complex nanoaggregates” (ICONs). The latter were thus prepared by appropriately mixing the two copolymers, by varying each component from 0 to 100 wt%…

siRNA deliveryRNase PCellPharmaceutical Science02 engineering and technology010402 general chemistry01 natural sciencesArticleAnalytical Chemistrylcsh:QD241-441EGF; inulin; PEG; siRNA delivery; targeting; tumourlcsh:Organic chemistryEpidermal growth factorNeoplasmsDrug DiscoveryPEG ratioZeta potentialmedicineCopolymerHumansDoxorubicinPhysical and Theoretical ChemistryRNA Small InterferingtargetingEGFDrug CarriersinulinChemistrytumourOrganic ChemistryTransfection021001 nanoscience & nanotechnologyPEG0104 chemical sciencesNanostructuresmedicine.anatomical_structureSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoChemistry (miscellaneous)BiophysicsMCF-7 CellsMolecular Medicine0210 nano-technologymedicine.drugMolecules (Basel, Switzerland)
researchProduct

A fluorescence study of the loading and time stability of doxorubicin in sodium cholate/PEO-PPO-PEO triblock copolymer mixed micelles

2019

Abstract Hypothesis Doxorubicin hydrochloride (DX) is one of the most powerful anticancer agents though its clinical use is impaired by severe undesired side effects. DX encapsulation in nanocarrier systems has been introduced as a mean to reduce its toxicity. Micelles of the nonionic triblock copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) (PEO-PPO-PEO), are very promising carrier systems. The positive charge of DX confines the drug to the hydrophilic corona region of the micelles. The use of mixed micelles of PEO-PPO-PEO copolymers and a negatively charged bile salt should favour the solubilization of DX in the apolar core region of the micelles. Experiments We st…

small angle X-raymacromolecular substances02 engineering and technology010402 general chemistry01 natural sciencesMicelledoxorubicinFluorescence spectroscopyfluorescence; doxorubicin; pluronics bile salts; dynamic light scattering; small angle X-ray; scattering drug-deliveryPolyethylene GlycolsBiomaterialsColloid and Surface ChemistryDynamic light scatteringX-Ray DiffractionScattering Small AngleCopolymerMicellesDrug CarriersAqueous solutionAntibiotics AntineoplasticSmall-angle X-ray scatteringChemistrytechnology industry and agricultureWaterdynamic light scatteringPoloxamer021001 nanoscience & nanotechnologySodium Cholate0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic Materialspluronics bile saltsSpectrometry FluorescenceChemical engineeringSolubilityPropylene Glycolsscattering drug-deliveryfluorescenceNanocarriers0210 nano-technology
researchProduct

On the Choice of the Extracellular Vesicles for Therapeutic Purposes

2019

Extracellular vesicles (EVs) are lipid membrane vesicles released by all human cells and are widely recognized to be involved in many cellular processes, both in physiological and pathological conditions. They are mediators of cell-cell communication, at both paracrine and systemic levels, and therefore they are active players in cell differentiation, tissue homeostasis, and organ remodeling. Due to their ability to serve as a cargo for proteins, lipids, and nucleic acids, which often reflects the cellular source, they should be considered the future of the natural nanodelivery of bio-compounds. To date, natural nanovesicles, such as exosomes, have been shown to represent a source of diseas…

theranosticsregenerative medicineReviewexosomesBiologyRegenerative medicineExtracellular vesiclesCatalysisTheranostic NanomedicineCatalysiInorganic Chemistrylcsh:Chemistry03 medical and health sciencesParacrine signallingExtracellular Vesicles0302 clinical medicineDrug Delivery SystemsNeoplasmsAnimalsHumansPhysical and Theoretical ChemistryLipid bilayerMolecular Biologylcsh:QH301-705.5Tissue homeostasisSpectroscopy030304 developmental biology0303 health sciencesDrug CarriersVesicleOrganic ChemistrybiomarkersComputer Science Applications1707 Computer Vision and Pattern RecognitionBiological TransportGeneral MedicineBiomarkerMicrovesiclesnanodelivery3. Good healthComputer Science ApplicationsCell biologyExosomeTheranosticlcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisSignal transductionextracellular vesicles (EVs)Signal TransductionInternational Journal of Molecular Sciences
researchProduct